{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:45:05Z","timestamp":1788983105275,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drudis.2026.104697","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:52:13Z","timestamp":1778759533000},"page":"104697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in siRNA and synbiotic therapies for colorectal cancer: a molecular and microbiota perspective"],"prefix":"10.1016","volume":"31","author":[{"given":"Monika","family":"Vishwakarma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuttiappan","family":"Anitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumel","family":"Ashique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9127-4469","authenticated-orcid":false,"given":"Neeraj","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104697_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.drudis.2026.104697_b0010","doi-asserted-by":"crossref","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.drudis.2026.104697_b0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.drudis.2026.104697_b0020","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.drudis.2026.104697_b0025","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2026.104697_b0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Ann Rev Pathol Mech Dis"},{"key":"10.1016\/j.drudis.2026.104697_b0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Comprehensive Cancer Network"},{"key":"10.1016\/j.drudis.2026.104697_b0040","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.drudis.2026.104697_b0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","article-title":"Microbes, microbiota, and colon cancer","volume":"15","author":"Sears","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2026.104697_b0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104697_b0055","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.3892\/mmr.2015.4124","article-title":"Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer","volume":"12","author":"Gao","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.drudis.2026.104697_b0060","first-page":"925","article-title":"Bifidobacteria and their role as members of the human gut microbiota","volume":"7","author":"O\u2019Callaghan","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2026.104697_b0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008362","article-title":"RNAi therapies: drugging the undruggable","volume":"6","author":"Wu","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.drudis.2026.104697_b0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104697_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2020.526455","article-title":"siRNA specificity: RNAi mechanisms and strategies to reduce off-target effects","volume":"11","author":"Neumeier","year":"2021","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.drudis.2026.104697_b0080","article-title":"Mechanisms and prospects of circular RNAs and their interacting signaling pathways in colorectal cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104697_b0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12029-021-00667-1","article-title":"Combination therapy with KRAS and P38\u03b1 siRNA suppresses colorectal cancer growth and development in SW480 cell line","volume":"53","author":"Kamran","year":"2022","journal-title":"J Gastrointestinal Cancer"},{"key":"10.1016\/j.drudis.2026.104697_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107082","article-title":"Novel siRNA delivery system targeting \u03b2-catenin in colorectal cancer cells: synergistic effect with 5-fluorouracil","author":"Ghareeb","year":"2025","journal-title":"J Drug Del Sci Technol"},{"key":"10.1016\/j.drudis.2026.104697_b0095","article-title":"Co-delivery of Doxorubicin and VEGF siRNA using carcinoembryonic antigen-targeted chitosan nanoparticles for colorectal cancer","volume":"101","author":"Momin","year":"2024","journal-title":"J Drug Del Sci Technol"},{"key":"10.1016\/j.drudis.2026.104697_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107185","article-title":"Preparation of co-loaded HHLA2 and EGFR siRNA nanoparticles and its delivery in colorectal cancer cells","author":"Zhang","year":"2025","journal-title":"J Drug Del Sci Technol"},{"key":"10.1016\/j.drudis.2026.104697_b0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/biom15010035","article-title":"Targeting invasion: the role of MMP-2 and MMP-9 Inhibition in colorectal cancer therapy","volume":"15","author":"Shoari","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2026.104697_b0185","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.18632\/oncotarget.27109","article-title":"Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles","volume":"10","author":"Strand","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104697_b0190","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211004414","article-title":"Long noncoding RNA LINC01296 plays an oncogenic role in colorectal cancer by suppressing p15 expression","volume":"49","author":"Xu","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.drudis.2026.104697_b0195","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1021\/acsabm.5c00489","article-title":"Nanotechnology-enhanced siRNA delivery: revolutionizing cancer therapy","volume":"8","author":"Esmaeilpour","year":"2025","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.drudis.2026.104697_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1395966","article-title":"The impact of pre-, pro-and synbiotics supplementation in colorectal cancer treatment: a systematic review","volume":"14","author":"Moreira","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104697_b0110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/cancers15020483","article-title":"The role of pharmacotherapy in treatment of meningioma: a systematic review","volume":"15","author":"Shahbandi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.drudis.2026.104697_b0115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/ijms9050854","article-title":"Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence","volume":"9","author":"Liong","year":"2008","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104697_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.634874","article-title":"Butyrate suppresses glucose metabolism of colorectal cancer cells via GPR109a-AKT signaling pathway and enhances chemotherapy","volume":"8","author":"Geng","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.drudis.2026.104697_b0125","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/microorganisms9061325","article-title":"Preventing colorectal cancer through prebiotics","volume":"9","author":"Mahdavi","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.drudis.2026.104697_b0130","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/cells12091244","article-title":"A probiotic formula for modulation of colorectal cancer risk via reducing CRC-associated bacteria","volume":"12","author":"Liang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2026.104697_b0135","doi-asserted-by":"crossref","DOI":"10.1177\/11795549231188225","article-title":"Potential ability of probiotics in the prevention and treatment of colorectal cancer","volume":"17","author":"Zhao","year":"2023","journal-title":"Clin Med Insight Oncol"},{"key":"10.1016\/j.drudis.2026.104697_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CM9.0000000000002955","article-title":"Probiotics intervention in colorectal cancer: from traditional approaches to novel strategies","volume":"137","author":"Ha","year":"2024","journal-title":"Chinese Med J"},{"key":"10.1016\/j.drudis.2026.104697_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1158200","article-title":"Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?","volume":"14","author":"Dong","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104697_b0150","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3748\/wjg.v29.i14.2078","article-title":"Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: current perspectives","volume":"29","author":"Roy","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.drudis.2026.104697_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104871","article-title":"Beneficial and anti-inflammatory effects of formulated prebiotics, probiotics, and synbiotics in normal and acute colitis mice","volume":"88","author":"Wong","year":"2022","journal-title":"J Funct Foods"},{"key":"10.1016\/j.drudis.2026.104697_b0160","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.drudis.2026.104697_b0165","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/1751-7915.12789","article-title":"Synbiotic approaches to human health and well\u2010being","volume":"10","author":"Gurry","year":"2017","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.drudis.2026.104697_b0170","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000508328","article-title":"Gut microbiota dysbiosis drives the development of colorectal cancer","volume":"102","author":"Fan","year":"2021","journal-title":"Digestion"},{"key":"10.1016\/j.drudis.2026.104697_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14302","article-title":"The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer","volume":"46","author":"Alam","year":"2022","journal-title":"J Food Biochem"},{"key":"10.1016\/j.drudis.2026.104697_b0205","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1186\/s12885-025-14315-5","article-title":"Anti-cancer properties of chitosan\/Lactobacillus acidophilus secretome nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma (Caco-2) cell line","volume":"25","author":"Saberpour","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drudis.2026.104697_b0210","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jcmgh.2021.06.001","article-title":"Lactobacillus rhamnosus GG orchestrates an antitumor immune response","volume":"12","author":"Owens","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.drudis.2026.104697_b0215","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.canlet.2019.11.019","article-title":"Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota","volume":"469","author":"Chen","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2026.104697_b0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2036.2010.04492.x","article-title":"Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post\u2010operative infectious complications in colorectal cancer surgery\u2013a double\u2010blind study","volume":"33","author":"Liu","year":"2011","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.drudis.2026.104697_b0225","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/nu13072439","article-title":"Gut microbiota and probiotics\/synbiotics for modulation of immunity in critically ill patients","volume":"13","author":"Shimizu","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.drudis.2026.104697_b0230","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1470-2045(18)30952-5","article-title":"Modulating the microbiome to improve therapeutic response in cancer","volume":"20","author":"McQuade","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.drudis.2026.104697_b0235","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2155019","article-title":"Technical versus biological variability in a synthetic human gut community","volume":"15","author":"van de Velde","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.drudis.2026.104697_b0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.chom.2015.12.016","article-title":"Taking it personally: personalized utilization of the human microbiome in health and disease","volume":"19","author":"Zmora","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2026.104697_b0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2026.104697_b0250","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104697_b0255","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251365700","article-title":"Harnessing the gut microbiome in cancer immunotherapy: mechanisms, challenges, and routes to personalized medicine \u2013 a systematic review","volume":"24","author":"Dayhimi","year":"2025","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.drudis.2026.104697_b0260","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/biom15040504","article-title":"Leveraging microbiome translational research in immuno-oncology for clinical-practice changes","volume":"15","author":"Alves Costa Silva","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2026.104697_b0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4252\/wjsc.v15.i5.281","article-title":"How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells","volume":"15","author":"D\u00edaz","year":"2023","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.drudis.2026.104697_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190810","article-title":"Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity","volume":"14","author":"Mowat","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104697_b0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2022.08.010","article-title":"Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer","volume":"31","author":"Wang","year":"2023","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.drudis.2026.104697_b0280","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3390\/cancers15041152","article-title":"Genotoxins: the mechanistic links between Escherichia coli and colorectal cancer","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.drudis.2026.104697_b0285","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41577-023-00951-0","article-title":"Role of the microbiota in response to and recovery from cancer therapy","volume":"24","author":"Blake","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.drudis.2026.104697_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1471273","article-title":"Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes","volume":"15","author":"Yan","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104697_b0295","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1007\/s13346-023-01361-4","article-title":"Innate immune regulations and various siRNA modalities","volume":"13","author":"Kaushal","year":"2023","journal-title":"Drug Del Transl Res"},{"key":"10.1016\/j.drudis.2026.104697_b0300","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/ph17101389","article-title":"Targeting tumor hypoxia with nanoparticle-based therapies: challenges, opportunities, and clinical implications","volume":"17","author":"Debnath","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drudis.2026.104697_b0305","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.drudis.2026.104697_b0310","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12876-025-03968-y","article-title":"The current status and prospects of gut microbiota combined with PD-1\/PD-L1 inhibitors in the treatment of colorectal cancer: a review","volume":"25","author":"Deng","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.drudis.2026.104697_b0315","article-title":"Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1\/PD-L1 therapy","author":"Li","year":"2026","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.drudis.2026.104697_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124689","article-title":"Intestinal probiotic-based nanoparticles for cytotoxic siRNA delivery in immunotherapy against cancer","volume":"665","author":"Zhu","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.drudis.2026.104697_b0325","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/17425255.2018.1530216","article-title":"Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug\u2013microbiome interactions","volume":"14","author":"Aziz","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.drudis.2026.104697_b0330","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101986R","article-title":"Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism","volume":"36","author":"Dikeocha","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2026.104697_b0335","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41579-023-00973-4","article-title":"The microbial landscape of colorectal cancer","volume":"22","author":"White","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.drudis.2026.104697_b0340","series-title":"The Role of Bacterial Beta Glucuronidase Activity in Irinotecan-Induced Diarrhea","author":"Ebuzoeme","year":"2021"},{"key":"10.1016\/j.drudis.2026.104697_b0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/17435889.2024.2443388","article-title":"Bacteria-tumor symbiosis destructible novel nanocatalysis drug delivery systems for effective tumor therapy","volume":"20","author":"Zang","year":"2025","journal-title":"Nanomedicine"},{"key":"10.1016\/j.drudis.2026.104697_b0350","article-title":"Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony","volume":"11","author":"Zhou","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.drudis.2026.104697_b0355","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxad032","article-title":"The role of gut microbiota and metabolites in regulating the immune response in drug-induced enteritis","volume":"134","author":"Chen","year":"2023","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.drudis.2026.104697_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101518","article-title":"Rational design of lipid nanoparticles for enabling gene therapies","volume":"33","author":"Brimacombe","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.drudis.2026.104697_b0365","article-title":"Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment","volume":"31","author":"Han","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.drudis.2026.104697_b0370","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/17512433.2022.2136166","article-title":"Clinical pharmacology of siRNA therapeutics: current status and future prospects","volume":"15","author":"Abosalha","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.drudis.2026.104697_b0375","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.7150\/thno.103636","article-title":"Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy","volume":"15","author":"Shao","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2026.104697_b0380","first-page":"1","article-title":"Gut dysbiosis in oncology: a risk factor for immunoresistance","author":"Almonte","year":"2026","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2026.104697_b0385","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3390\/microorganisms13081894","article-title":"Therapeutic potential of probiotics in metabolic dysfunction-associated steatohepatitis: a comprehensive review","volume":"13","author":"Wang","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.drudis.2026.104697_b0390","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000268","article-title":"Probiotic\/synbiotic treatment and postoperative complications in colorectal cancer patients: systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Amitay","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.drudis.2026.104697_b0395","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3390\/nu17132117","article-title":"The gut\u2019s secret code: bowel microbiota as a biomarker for adaptation","volume":"17","author":"Braszczy\u0144ska-Sochacka","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.drudis.2026.104697_b0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1559480","article-title":"Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling","volume":"16","author":"Eslami","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104697_b0405","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1007\/s11033-023-08749-y","article-title":"Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities","volume":"50","author":"Isazadeh","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.drudis.2026.104697_b0410","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2342187","article-title":"Unraveling the effect of immunogenicity on the PK\/PD, efficacy, and safety of therapeutic proteins","volume":"2016","author":"Smith","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.drudis.2026.104697_b0415","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/D0TB00649A","article-title":"Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy","volume":"8","author":"Zhou","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.drudis.2026.104697_b0420","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2305716","article-title":"Exploring substrate\u2013microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions","volume":"16","author":"Speckmann","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.drudis.2026.104697_b0425","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12275-009-0124-8","article-title":"Isolation, characterization, and evaluation of wild isolates of Lactobacillus reuteri from pig feces","volume":"47","author":"Lee","year":"2009","journal-title":"J Microbiol"},{"issue":"suppl. 2","key":"10.1016\/j.drudis.2026.104697_b0430","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and safety of probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.drudis.2026.104697_b0435","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3920\/BM2013.0046","article-title":"Probiotic and synbiotic safety in infants under two years of age","volume":"5","author":"van den Nieuwboer","year":"2014","journal-title":"Benefic Microbes"},{"key":"10.1016\/j.drudis.2026.104697_b0440","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1086\/523339","article-title":"Probiotics in the United States","volume":"46","author":"Market","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.drudis.2026.104697_b0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-374938-3.00002-5","article-title":"Assessment of prebiotics and probiotics: an overview","author":"Anad\u00f3n","year":"2010","journal-title":"Bioactive Foods Promot Health"},{"key":"10.1016\/j.drudis.2026.104697_b0450","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: state-of-the-art and future perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.drudis.2026.104697_b0455","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fimmu.2017.00331","article-title":"RNA interference-induced innate immunity, off-target effect, or immune adjuvant?","volume":"8","author":"Meng","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104697_b0460","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2026.104697_b0465","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ijfoodmicro.2010.02.031","article-title":"Probiotics and prebiotics in animal feeding for safe food production","volume":"141","author":"Gagg\u00eca","year":"2010","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.drudis.2026.104697_b0470","series-title":"Human Microbiome: Techniques, Strategies and Therapeutic Potential","first-page":"657","article-title":"Regulatory considerations for microbiome-based therapeutics","author":"Waheed","year":"2024"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:21:00Z","timestamp":1785946860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1359644626001029"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104697","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in siRNA and synbiotic therapies for colorectal cancer: a molecular and microbiota perspective","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104697"}}